Blood Grouping Reagents Market :Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Blood Grouping Reagent Market by Product (Consumables, Instruments), by Technique (PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Other Techniques), by Test Type (Antibody Screening, HLA Typing, Cross-Matching Tests, ABO Blood Tests, Antigen Typing), by End-user (Hospitals, Blood Banks, Clinical Laboratories) and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare

Description
Table Of Content
Company Profile

Report

Description

M2M Satellite Communication Market size was valued at USD 2,541 billion in 2021, growing at a CAGR of 7.73% from 2022-28. Blood grouping reagents Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product, technique, test type, end user and region. This report market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in Blood grouping reagents. Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks for the determination and identification of antibody type in patient’s and donors blood, in order to ensure the effective and safe transfusion of blood and to reduce the risks causing infections. Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.

Blood Grouping Reagent Market

MARKET SUMMARY

7.73%

Study Period– 2021 – 2027
Base Year– 2020
CAGR– 7.73%
Largest Market– Europe
Fastest Growing Market– North America

Blood Grouping Reagent Market Analysis

Blood grouping reagents are the vital tools in diagnostic laboratories for blood group serology. Rise number of blood transfusion procedures is anticipated to pose great demand for the blood grouping reagents.
In addition to this extended use of blood group reagents for the purpose of research is anticipated to propel the market growth of blood grouping reagents.
As per the American Cancer Society, about 1.69 million people are going to be diagnosed with cancer in 2017. Which may have dire need of blood for the victims during chemotherapy treatment. Every day in U.S., approximately about 36,000 units of RBC, 7,000 units of platelets and 10,000 units of plasma are required and roughly 21 million blood components are transfused every year in U.S.
In July 2017, Bio-Rad Laboratories, Inc., received U.S. FDA clearance for IH-1000 blood typing instrument to market in the US
In February 2017, Immucor, Inc., launched MIA FORA NGS FLEX HLA Typing Assay which provides comprehensive coverage up to 11 HLA genes
In November 2013, Grifols, acquired Novartis AG transfusion diagnostics unit to strengthen its Diagnostic Division and Bioscience Division

Market Leaders

Grifols, S.A. (Spain)
Bio-Rad Laboratories, Inc. (U.S.)
Immucor, Inc. (U.S.)
Quotient, Ltd. (U.S.)
Novacyt Group (France)
Ortho Clinical Diagnostics, Inc. (U.S.)
BAG Healthcare GmbH (Germany)
Day medical SA (Switzerland)
Rapid Labs (U.K.)
AXO Science (France)
DIAGAST (France)

Blood Grouping Reagent Market

Drivers and Restraints

Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lacking in the awareness, lack of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.

Blood Grouping Reagent Market Regional Analysis

North America dominates the market

On the basis of geographical regions, blood grouping reagents market is segmented as Latin America, North America, Asia Pacific, Europe, The Middle East and Africa. North America holds largest market share due to favourable reimbursement policies for surgeries, and rising incidence of the major blood disorders. Asia-Pacific market is anticipated to show significant growth rate due to rise in incidence and prevalence rate of chronic disorders in Asian countries.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Blood Grouping Reagent Market Segmentation

Product

Consumables
Instruments

Technique

PCR-based and Microarray Technique
Assay-Based Techniques
Massively Parallel Sequencing Techniques
Other Techniques

Test Type

Antibody Screening
HLA Typing
Cross-Matching Tests
ABO Blood Tests
Antigen Typing

End-user

Hospitals
Blood Banks
Clinical Laboratories

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

Executive Summary
Global Blood Grouping Reagents Market Introduction

2.1. Global Blood Grouping Reagents Market – Taxonomy

2.2. Global Blood Grouping Reagents Market –Definitions

2.2.1. Product

2.2.2. Technique

2.2.3. Test Type

2.2.4. End-User

Global Blood Grouping Reagents Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Blood Grouping Reagents Market Dynamic Factors – Impact Analysis

3.6. Global Blood Grouping Reagents Market – Regulations

3.6.1. U.S.

3.6.2. Europe

3.7. Global Blood Grouping Reagents Market –Trends

Global Blood Grouping Reagents Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

4.1. Market Analysis, 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Oppurtunity Analysis

Global Blood Grouping Reagents Market, By Product, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.1. Consumables

5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Instruments

5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

Global Blood Grouping Reagents Market Forecast, By Technique, 2013 – 2017 and Forecast, 2018 – 2024

6.1. PCR-based and Microarray Technique

6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Assay-Based Techniques

6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Massively Parallel Sequencing Techniques

6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Other Techniques

6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

Global Blood Grouping Reagents Market Forecast, By Test Type, 2013 – 2017 and Forecast, 2018 – 2024

7.1. Antibody Screening

7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. HLA Typing

7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Cross-Matching Tests

7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. ABO Blood Tests

7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Antigen Typing

7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

Global Blood Grouping Reagents Market Forecast, By End – Use, 2013 – 2017 and Forecast, 2018 – 2024

8.1. Hospitals

8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Blood Banks

8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Clinical Laboratories

8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

Global Blood Grouping Reagents Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

9.1. North America

9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Blood Grouping Reagents Market – Opportunity Analysis Index, By Product, By Technique, By Test Type, By End – Use and Region, 2018 – 2024

North America Blood Grouping Reagents Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

10.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Consumables

10.1.2. Instruments

10.2. Technique Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. PCR-based and Microarray Technique

10.2.2. Assay-Based Techniques

10.2.3. Massively Parallel Sequencing Techniques

10.2.4. Other Techniques

10.3. Test Type Analysis, 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Antibody Screening

10.3.2. HLA Typing

10.3.3. Cross-Matching Tests

10.3.4. ABO Blood Tests

10.3.5. Antigen Typing

10.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.4.1. Hospitals

10.4.2. Blood Banks

10.4.3. Clinical Laboratories

10.5. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. U.S.

10.5.2. Canada

10.6. North America Blood Grouping Reagents Market – Opportunity Analysis Index, By Product, By Technique, By Test Type, By End – Use and Country, 2018 – 2024

10.7. North America Blood Grouping Reagents Market Dynamics – Trends

Europe Blood Grouping Reagents Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

11.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Consumables

11.1.2. Instruments

11.2. Technique Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. PCR-based and Microarray Technique

11.2.2. Assay-Based Techniques

11.2.3. Massively Parallel Sequencing Techniques

11.2.4. Other Techniques

11.3. Test Type Analysis, 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.3.1. Antibody Screening

11.3.2. HLA Typing

11.3.3. Cross-Matching Tests

11.3.4. ABO Blood Tests

11.3.5. Antigen Typing

11.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.4.1. Hospitals

11.4.2. Blood Banks

11.4.3. Clinical Laboratories

11.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Poland

11.5.8. Rest of Europe

11.6. Europe Blood Grouping Reagents Market – Opportunity Analysis Index, By Product, By Technique, By Test Type, By End – Use and Country, 2018 – 2024

11.7. Europe Blood Grouping Reagents Market Dynamics – Trends

Asia-Pacific Blood Grouping Reagents Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

12.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Consumables

12.1.2. Instruments

12.2. Technique Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. PCR-based and Microarray Technique

12.2.2. Assay-Based Techniques

12.2.3. Massively Parallel Sequencing Techniques

12.2.4. Other Techniques

12.3. Test Type Analysis, 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Antibody Screening

12.3.2. HLA Typing

12.3.3. Cross-Matching Tests

12.3.4. ABO Blood Tests

12.3.5. Antigen Typing

12.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.4.1. Hospitals

12.4.2. Blood Banks

12.4.3. Clinical Laboratories

12.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Blood Grouping Reagents Market – Opportunity Analysis Index, By Product, By Technique, By Test Type, By End – Use and Country, 2018 – 2024

12.7. Asia-Pacific Blood Grouping Reagents Market Dynamics – Trends

Latin America Blood Grouping Reagents Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

13.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Consumables

13.1.2. Instruments

13.2. Technique Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1. PCR-based and Microarray Technique

13.2.2. Assay-Based Techniques

13.2.3. Massively Parallel Sequencing Techniques

13.2.4. Other Techniques

13.3. Test Type Analysis, 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Antibody Screening

13.3.2. HLA Typing

13.3.3. Cross-Matching Tests

13.3.4. ABO Blood Tests

13.3.5. Antigen Typing

13.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.4.1. Hospitals

13.4.2. Blood Banks

13.4.3. Clinical Laboratories

13.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Argentina

13.5.4. Venezuela

13.5.5. Rest of Latin America

13.6. Latin America Blood Grouping Reagents Market – Opportunity Analysis Index, By Product, By Technique, By Test Type, By End – Use and Country, 2018 – 2024

13.7. Latin America Blood Grouping Reagents Market Dynamics – Trends

Middle East and Africa Blood Grouping Reagents Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

14.1. Product Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Consumables

14.1.2. Instruments

14.2. Technique Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.2.1. PCR-based and Microarray Technique

14.2.2. Assay-Based Techniques

14.2.3. Massively Parallel Sequencing Techniques

14.2.4. Other Techniques

14.3. Test Type Analysis, 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.3.1. Antibody Screening

14.3.2. HLA Typing

14.3.3. Cross-Matching Tests

14.3.4. ABO Blood Tests

14.3.5. Antigen Typing

14.4. End -Use Analysis, 2012- 2016 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.4.1. Hospitals

14.4.2. Blood Banks

14.4.3. Clinical Laboratories

14.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. Israel

14.5.3. South Africa

14.5.4. Rest of MEA

14.6. MEA Blood Grouping Reagents Market – Opportunity Analysis Index, By Product, By Technique, By Test Type, By End – Use and Country, 2018 – 2024

14.7. MEA Blood Grouping Reagents Market Dynamics – Trends

Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Grifols, S.A. (Spain)

15.2.2. Bio-Rad Laboratories, Inc. (U.S.)

15.2.3. Immucor, Inc. (U.S.)

15.2.4. Quotient, Ltd. (U.S.)

15.2.5. Novacyt Group (France)

15.2.6. Ortho Clinical Diagnostics, Inc. (U.S.)

15.2.7. BAG Healthcare GmbH (Germany)

15.2.8. Day medical SA (Switzerland)

15.2.9. Rapid Labs (U.K.)

15.2.10. AXO Science (France)

15.2.11. DIAGAST (France)

Research Methodology
Key Assumptions and Acronyms

Description

search

Blood Grouping Reagents Market :Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Blood Grouping Reagent Market

Blood Grouping Reagent Market Analysis

Drivers and Restraints

North America dominates the market

Features of the Report

Product

Technique

Test Type

End-user

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE